NCT00083343View on ClinicalTrials.gov

Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Candidiasis
Interventions
DRUG

MK0991, caspofungin acetate/Duration of Treatment: variable

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00083343 - Caspofungin for the Treatment of Non-blood Candida Infections (0991-045) | Biotech Hunter | Biotech Hunter